New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 7, 2014
HIGHER: 21st Century Fox (FOXA), up 5.8%, upgraded at Cowen following the company's Q4 earnings results... Walgreen (WAG), up 2.8% after upgraded at Cantor... inContact (SAAS), up 18.5% after upgraded at Oppenheimer and Benchmark Co. after reporting better than expected Q2 results... CTI BioPharma (CTIC), up 4.5% after Pacritinib granted fast track designation by FDA... Stratasys (SSYS), up 8.6% after reporting earnings and raising its FY14 EPS view. Peers higher as well, with ExOne (XONE) up 5.3% and 3D Systems (DDD) up 2.9%... OncoGenex (OGXI), up 11.3% after appointing John A. Bencich CFO. UP AFTER EARNINGS: Horizon Pharma (HZNP), up 14.6%... Goodrich Petroleum (GDP), up 11.1%... SunEdison (SUNE), up 7%... Transocean (RIG), up 2.8%... Molycorp (MCP), up 13.7%. LOWER: Nanosphere (NSPH), down 31%, downgraded at Craig-Hallum following the company's Q2 earnings results... Thoratec (THOR), down 26%, downgraded at Goldman and Credit Suisse following lower than expected second quarter revenues and lowering FY14 guidance... PhotoMedex (PHMD), down 10% after earnings, disclosing receipt of notice of default on credit facilities... Atmel (ATML), down 4.2%, downgraded at BofA Merrill Lynch following its Q2 earnings results... Melco Crown (MPEL), down 5.2% after earnings, reporting Taiwan branch office indicted for alleged banking violations.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 >>
October 1, 2015
05:31 EDTCTICCTI BioPharma, Fred Hutchinson Cancer Research Center report research fellowship
Subscribe for More Information
September 30, 2015
18:07 EDTTHORS&P announces changes to the S&P 400, 500 indices
S&P 500 constituent Joy Global (JOY) will replace Thoratec (THOR) in the S&P MidCap 400, and Verisk Analytics (VRSK) will replace Joy Global in the S&P 500 after the close of trading on Wednesday, October 7. S&P 500 constituent St. Jude Medical (STJ) is acquiring Thoratec in a deal expected to be completed on or about that date, pending final approvals. Joy Global has a market capitalization more representative of the mid-cap market space.
17:19 EDTTHORJoy Global to replace Thoratec in S&P 400 as of 10/7 close
10:36 EDTSUNE, HZNPOptions with increasing implied volatility
Subscribe for More Information
09:47 EDTSSYSStratasys management to meet with Oppenheimer
Group luncheon to be held in New York on October 6 hosted by Oppenheimer.
08:30 EDTHZNPDepomed should be bought at current levels, says Roth Capital
Subscribe for More Information
07:42 EDTMPELMacau casinos have new concern with junket embezzlement scandal, WSJ says
Subscribe for More Information
07:05 EDTOGXIOncoGenex completes patient enrollment in clinical trial for bladder cancer
Subscribe for More Information
05:32 EDTSAASRingCentral adds cloud contact centre in UK
Subscribe for More Information
September 29, 2015
12:58 EDTHZNPHorizon Pharma's volatility at 52-week high
Subscribe for More Information
10:48 EDTSUNE, HZNPOptions with increasing implied volatility
Subscribe for More Information
09:40 EDTFOXA21st Century Fox, ValueAct Capital enter into agreement regarding ownership
Twenty-First Century Fox announced that it entered into a Nomination Agreement dated September 28 with ValueAct Capital Master Fund L.P., VA Partners I, LLC, ValueAct Capital Management, L.P., ValueAct Capital Management, LLC, ValueAct Holdings, L.P., ValueAct Holdings GP, LLC, Volpe Velox, L.P., Volpe Velox, LLC and Jeffrey W. Ubben. The ValueAct Group currently beneficially owns approximately 5.9% of the company's outstanding Class B Common Stock. Pursuant to the Nomination Agreement, and subject to the conditions set forth therein, the company agreed to nominate Ubben, the Founder, CEO and CIO of ValueAct Capital, for election to the company's Board at the company's annual meeting of stockholders to be held in 2015.Subject to certain exceptions, if at any time the ValueAct Group ceases to own at least 5% of the outstanding Class B Common Stock of the company, the company will no longer be required to nominate Ubben for election at the 2015 Annual Meeting and, if he previously joined the Board, Ubben will be required to resign from the Board. Under the Nomination Agreement, in the event that Ubben no longer serves as a company director prior to the Company's 2016 annual meeting of stockholders due to his death or disability, the company and the ValueAct Group shall work together to nominate a mutually acceptable replacement so long as the ValueAct Group continues to own at least 5% of the company's outstanding Class B Common Stock. For the duration of the Standstill Period, the ValueAct Group has agreed, among other things, that it will not: (i) in any way participate in any "solicitation" of proxies; (ii) in any way participate in any group with any persons who are not ValueAct affiliates with respect to the company's securities; (iii) acquire any beneficial or other ownership interest of (A) 7% or more of the company's Class B Common Stock outstanding at such time or (B) 7% or more of the company's Class A Common Stock outstanding at such time; (iv) knowingly sell the securities of the company to any person or entity that would own more than 4.9% of the outstanding shares of the Company's Class B Common Stock or 4.9% of the outstanding shares of the company's Class A Common Stock following such transaction; (v) effect or seek to effect any tender or exchange offer, merger, consolidation, acquisition, scheme, arrangement, business combination, recapitalization, reorganization, sale or acquisition of material assets, liquidation, dissolution or other extraordinary transaction involving the Company, or frustrate or seek to frustrate any extraordinary transaction proposed or endorsed by the company; (vi) engage in any short sale or similar derivative transaction related to the market price or value of the company's securities.
09:31 EDTFOXAValueAct agrees to 7% equity cap in standstill with 21st Century Fox
Subscribe for More Information
09:19 EDTMPELDeutsche Bank to hold a conference
Subscribe for More Information
09:10 EDTSAASinContact to hold a user conference
11th Annual User Conference: ICUC 2015 Legendary Journeys Ahead will be held in Salt Lake City, Utah on September 29-October 1.
08:38 EDTFOXA21st Century Fox, ValueAct Capital enter into agreement regarding ownership
Subscribe for More Information
08:37 EDTFOXA21st Century Fox nominates ValueAct CEO Jeffrey Ubben for election to board
Subscribe for More Information
07:58 EDTSUNESunEdison price target lowered to $19 from $23 at JPMorgan
Subscribe for More Information
06:05 EDTSUNETerraForm Global downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Paul Coster downgraded TerraForm Global (GLBL) to Neutral saying parent SunEdison (SUNE) is likely to focus on TerraForm Power (TERP), constraining the company's growth. He cut his price target for shares to $14 from 17.
05:05 EDTHZNPStocks with implied volatility movement; HZNP VRX
Stocks with implied volatility movement; Horizon Pharma (HZNP) 132, Valeant (VRX) 98 according to iVolatility.
1 | 2 | 3 | 4 | 5 | 6 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use